Ling Wang

Title: Ling Wang - Innovator in Peptide Agonist Discovery

Introduction

Ling Wang is a prominent inventor based in San Francisco, CA. She has made significant contributions to the field of peptide ligand discovery, particularly in developing methods for identifying agonists for membrane-bound receptors. Her innovative work has the potential to advance therapeutic strategies in various medical applications.

Latest Patents

Ling Wang holds a patent titled "Method for Discovery of Peptide Agonists." This invention focuses on a novel approach to peptide ligand discovery, specifically aimed at identifying agonists for membrane-bound receptors. The detection system she developed utilizes a 'tethered' ligand to probe receptor binding. The system comprises a membrane, a membrane-bound receptor, and a chimeric ligand presenting molecule. This chimeric protein forms the tethered ligand, which includes a membrane domain, a linker domain, a ligand domain, and a cleavable terminal domain. The ligands are exposed through the addition of a specific peptidase that cleaves at a designated sequence. The resulting interaction between the agonist and receptor allows for the isolation of the ligand sequence that produces a signal, utilizing sib selection.

Career Highlights

Ling Wang is affiliated with the University of California, where she continues her research and development in the field of peptide discovery. Her work has garnered attention for its innovative approach and potential applications in drug development.

Collaborations

Ling Wang collaborates with esteemed colleagues, including Mian Chen and Harold S. Bernstein, who contribute to her research endeavors and enhance the impact of her work.

Conclusion

Ling Wang's contributions to the field of peptide agonist discovery exemplify the innovative spirit of modern science. Her patent and ongoing research at the University of California highlight her role as a leading inventor in this critical area of study.